Northeast Investment Management’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$235K Hold
3,405
0.01% 173
2025
Q1
$236K Hold
3,405
0.01% 169
2024
Q4
$293K Sell
3,405
-155
-4% -$13.3K 0.01% 161
2024
Q3
$424K Hold
3,560
0.02% 143
2024
Q2
$508K Hold
3,560
0.02% 134
2024
Q1
$457K Hold
3,560
0.02% 140
2023
Q4
$368K Buy
3,560
+300
+9% +$31K 0.02% 148
2023
Q3
$296K Hold
3,260
0.02% 159
2023
Q2
$264K Buy
+3,260
New +$264K 0.01% 164
2022
Q2
Sell
-4,060
Closed -$225K 197
2022
Q1
$225K Hold
4,060
0.01% 195
2021
Q4
$227K Buy
+4,060
New +$227K 0.01% 195
2016
Q4
Sell
-80,214
Closed -$1.67M 162
2016
Q3
$1.67M Sell
80,214
-12,606
-14% -$262K 0.17% 83
2016
Q2
$2.5M Sell
92,820
-69,824
-43% -$1.88M 0.25% 71
2016
Q1
$4.41M Sell
162,644
-6,298
-4% -$171K 0.45% 60
2015
Q4
$4.91M Buy
168,942
+2,382
+1% +$69.2K 0.51% 56
2015
Q3
$4.52M Buy
166,560
+2,656
+2% +$72K 0.49% 60
2015
Q2
$4.49M Sell
163,904
-2,040
-1% -$55.9K 0.45% 61
2015
Q1
$4.43M Sell
165,944
-10,818
-6% -$289K 0.43% 60
2014
Q4
$3.74M Sell
176,762
-10,836
-6% -$229K 0.37% 64
2014
Q3
$4.47M Sell
187,598
-5,292
-3% -$126K 0.45% 61
2014
Q2
$4.46M Buy
192,890
+11,252
+6% +$260K 0.45% 60
2014
Q1
$4.15M Buy
181,638
+57,038
+46% +$1.3M 0.44% 63
2013
Q4
$2.3M Buy
124,600
+64,330
+107% +$1.19M 0.26% 74
2013
Q3
$1.02M Buy
+60,270
New +$1.02M 0.12% 95